GCM
RCKT icon

Graham Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Graham Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,743
Closed -$259K – 1457
2025
Q4 		$259K Sell
73,743
-59,769
-45% -$205K 0.01% 932
2025
Q3 		$435K Sell
133,512
-104,738
-44% -$330K 0.02% 670
2025
Q2 		$584K Buy
238,250
+227,100
+2,037% +$1.15M 0.02% 758
2025
Q1 		$74.4K Buy
+11,150
New +$110K ﹤0.01% 1224
2022
Q4 		– Sell
-68,126
Closed -$1.09M – 1297
2022
Q3 		$1.09M Buy
68,126
+4,759
+8% +$74.3K 0.05% 449
2022
Q2 		$871K Buy
63,367
+5,522
+10% +$65.8K 0.04% 483
2022
Q1 		$917K Buy
+57,845
New +$999K 0.04% 338

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return